Clinical Trials List
Protocol NumberNSC 102-2314-B-006 -065 -MY2
2013-08-01 - 2015-07-31
Phase II
Study ended1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 吳至行 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
0 participants
